Momordica charantia Extract Induces Apoptosis in Human Cancer Cells through Caspase- and Mitochondria-Dependent Pathways
Figure 2
Cell cycle distribution of MCME-treated cancer cells. Cells were treated with MCME for 6, 12, 18, and 24 hours at a concentration of 0.35, 0.25, 0.3, and 0.25 mg/mL for Hone-1, AGS, HCT-116, and CL1-0 cells, respectively. MCME-treated cells were analyzed by flow cytometry using PI staining to determine the population at sub-G1 phase. All experiments were performed in triplicate, and results were expressed as mean ± SD. Ctrl indicates the control group of cells.
